Researching veterinary diseases can help design nanovaccines to prevent similar diseases in humans
Our nanovaccine and nanotherapeutic research includes a focus on animal health and veterinary diseases such as swine flu, avian flu, and bovine respiratory syncytial virus.
The Nanovaccine Institute is pioneering the development of novel nano-based countermeasures, including vaccines and therapeutics, against respiratory infections that impact animal health. In particular, Nanovaccine Institute researchers are working on countermeasures against infections that impact many sectors of the agriculture industry.
Infections addressed include:
- Porcine Reproductive and Respiratory Syndrome (PRRS)
- Avian influenza
- Infectious bronchitis
- Bovine Respiratory Disease (BRD)
- Johne’s disease
- Equine herpes virus
Nanovaccine Institute researchers are collaborating to develop single dose vaccines against these diseases that can induce rapid and long-lived mucosal and systemic immunity, which current vaccines cannot provide. They are working closely with veterinary scientists, industry practitioners, and regulatory experts to ensure that these countermeasures can be safely deployed in the field. These close collaborations are setting the stage for many of these technologies to enter clinical trials.